The adenosine A1 receptor agonist WAG 994 suppresses acute kainic acid-induced status epilepticus in vivo
- 29 June 2020
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 176, 108213
Abstract
No abstract availableKeywords
Funding Information
- NIH-NINDS (R01NS100706)
- NIH-NINDS (R21NS098009)
- American Epilepsy Society
- Lennox Gastaut Syndrome Foundation
- AES Lennox and Lombroso Fund
- Boehringer Ingelheim Fonds
This publication has 59 references indexed in Scilit:
- Experimental Models of Status Epilepticus and Neuronal Injury for Evaluation of Therapeutic InterventionsInternational Journal of Molecular Sciences, 2013
- Adenosine receptors as drug targets — what are the challenges?Nature Reviews Drug Discovery, 2013
- Enhanced actions of adenosine in medial entorhinal cortex layer II stellate neurons in temporal lobe epilepsy are mediated via A1‐receptor activationEpilepsia, 2011
- Management of refractory status epilepticus in adults: still more questions than answersThe Lancet Neurology, 2011
- A ketogenic diet suppresses seizures in mice through adenosine A1 receptorsJournal of Clinical Investigation, 2011
- Treatment of early and late kainic acid‐induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466Epilepsia, 2009
- A1adenosine receptor agonists and their potential therapeutic applicationsExpert Opinion on Investigational Drugs, 2008
- Adenosine and ATP Link PCO2 to Cortical Excitability via pHNeuron, 2005
- Mortality Associated with Status EpilepticusEpilepsy Currents, 2004
- The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental painBritish Journal of Clinical Pharmacology, 1999